# A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis

> **NCT06640257** · PHASE3 · RECRUITING · sponsor: **Suzhou Suncadia Biopharmaceuticals Co., Ltd.** · enrollment: 200 (estimated)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** SHR-1314 injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06640257
- **Lead sponsor:** Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-04
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06640257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06640257, "A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06640257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*